A Comparative study of dexmedetomidine and labetalol for attenuating hemodynamic response to laryngoscopy and intubation in patients coming for elective surgeries under general anaesthesia
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 108
- 试验地点
- 1
- 主要终点
- To compare the efficacy of dexmedetomidine 1 µg/kg and labetalol 0.3
研究概览
简要总结
The process of endotracheal intubation, commonly used in various medical procedures, plays a crucial role in ensuring adequate ventilation and oxygenation of patients. However, this procedure can also induce significant physiological changes, particularly in the cardiovascular system, leading to hemodynamic instability. Understanding the hemodynamic changes during intubation is of paramount importance for healthcare professionals to effectively manage and minimize the associated risks.General anesthesia with endotracheal intubation is very common now a days. Endotracheal intubation using direct laryngoscopes is associated with stimulation of trachea and larynx. This will result in tachycardia and rise in blood pressure .Eventhough the responses are short lived and causes less consequences in healthy patients. These changes can be fatal in patients with preexisting heart disease, hypertension or cerebrovascular condition, complications like left ventricular failure, intracranial hemorrhage and myocardial ischemia can occur as a result of tachycardia and sudden rise in blood pressure. Under such circumstances it becomes a necessity to attenuate such reflex responses associated with endotracheal intubation and laryngoscopy to achieve a balance between the myocardial oxygen supply and demand.Common strategies include deepening the depth of anesthesia, topical anaesthesia of the oropharynx, intravenous lignocaine, intravenous fentanyl, alfentanil, sodium nitroprusside, beta adrenergic blocking drugs, alpha-2-adrenergic agonists, calcium channel blockers etc.The advantages of Dexmedetomidine as premedicant in anaesthesia include sedation, analgesia, anxiolysis and improved hemodynamic stability. Because of these beneficial properties it has been found that minimum alveolar concentration (MAC) of volatile anaesthetic agent also decreases significantly up to 90% and hence decreases the requirement of anaesthetics.It has been found that it decrease the hemodynamic response to laryngoscopy and intubation.Labetalol is combined α1andβ antagonist and pre induction intravenous labetalol attenuated the hemodynamic response to endotracheal intubation.Labetalol is suitable for blunting the hemodynamic changes associated with laryngoscopy and intubationThis study between comparison of IV dexmedetomidine and IV labetalol aims at finding out which drug is better at blunting the stress response associated with laryngoscopy and intubation.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- Participant and Investigator Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)(—)
- 性别
- All
入选标准
- •ASA Grade I & II ,Elective surgery requiring general anesthesia with endotracheal intubation.
排除标准
- •Patient contraindicated to beta blockers,Hypertensive patients,patients on anti hypertensives,Systolic BP less than 120 mm of hg , HR less than 60/min,Evidence of anticipated difficult airway,Drug allergy to dexmedetomidine and labetalol,Pregnant patients,Ischemic heart disease,Cerebrovascular accidents,patient refusal,intubation attempts more than 2 times.
结局指标
主要结局
To compare the efficacy of dexmedetomidine 1 µg/kg and labetalol 0.3
时间窗: 1)after drug administration | 2)after induction | 3)1 minute after induction | 4)2 minute after induction | 5)3 minute after induction | 6)5 minute after induction | 7)10 minute after induction | 8)15 minute after induction
mg/kg in blunting the hemodynamic stress response to laryngoscopy and intubation
时间窗: 1)after drug administration | 2)after induction | 3)1 minute after induction | 4)2 minute after induction | 5)3 minute after induction | 6)5 minute after induction | 7)10 minute after induction | 8)15 minute after induction
次要结局
- 1)To observe for any adverse effect related to dexmedetomidine and(labetalol)
研究者
Dr Harikrishna S
Rajendra Institute of Medical Sciences
